Increasing incidence and pretransplantation screening of hepatocellular carcinoma

被引:22
作者
Everson, GT [1 ]
机构
[1] Univ Colorado, Sch Med, Denver, CO 80262 USA
关键词
D O I
10.1053/jlts.2000.1918
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1. The incidence of hepatocellular cancer (HCC) in the United States and other traditionally "low-incidence" countries is increasing. 2. The rise in incidence of HCC is related to chronic hepatitis C. 3. Timely performance of liver transplantation is curative in patients with early-stage HCC. 4. Cirrhotic patients, especially those with viral hepatitis, should be screened for HCC. 5. The performance characteristics of current tests are suboptimal, but serial ultrasonography and alphafetaprotein are recommended. 6. Estimated medical charges related to screening and treatment suggest that $285,294 is required per "cured" case. Assuming that this cure is associated with a 75% to 85% chance for high-quality 10-year survival, the charges approximate $35,000 to $40,000/quality-adjusted life-year (QALY). This cost-benefit analysis is nearly identical to published rates for breast cancer screening ($30,000/ QALY).
引用
收藏
页码:S2 / S10
页数:9
相关论文
共 43 条
[31]   DECIDING ABOUT SCREENING [J].
PAUKER, SG .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (11) :901-902
[32]  
PENN I, 1991, SURGERY, V110, P726
[33]   RELATION OF THE HEPATITIS-B VIRUS CARRIER STATE TO HEPATOCELLULAR-CARCINOMA [J].
POPPER, H ;
SHAFRITZ, DA ;
HOOFNAGLE, JH .
HEPATOLOGY, 1987, 7 (04) :764-772
[34]   SCREENING FOR HEPATOCELLULAR-CARCINOMA IN HIGH-RISK INDIVIDUALS [J].
REGAN, LS .
ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (08) :1741-1744
[35]   ACCURACY OF RADIOLOGY IN DETECTION OF HEPATOCELLULAR-CARCINOMA BEFORE LIVER-TRANSPLANTATION [J].
RIZZI, PM ;
KANE, PA ;
RYDER, SD ;
RAMAGE, JK ;
GANE, E ;
TAN, KC ;
PORTMANN, B ;
KARANI, J ;
WILLIAMS, R .
GASTROENTEROLOGY, 1994, 107 (05) :1425-1429
[36]   A SEROLOGIC FOLLOW-UP OF THE 1942 EPIDEMIC OF POSTVACCINATION HEPATITIS IN THE UNITED-STATES-ARMY [J].
SEEFF, LB ;
BEEBE, GW ;
HOOFNAGLE, JH ;
NORMAN, JE ;
BUSKELLBALES, Z ;
WAGGONER, JG ;
KAPLOWITZ, N ;
KOFF, RS ;
PETRINI, JL ;
SCHIFF, ER ;
SHOREY, J ;
STANLEY, MM .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (16) :965-970
[37]   GROWTH-RATE OF ASYMPTOMATIC HEPATOCELLULAR-CARCINOMA AND ITS CLINICAL IMPLICATIONS [J].
SHEU, JC ;
SUNG, JL ;
CHEN, DS ;
YANG, PM ;
LAI, MY ;
LEE, CS ;
HSU, HC ;
CHUANG, CN ;
YANG, PC ;
WANG, TH ;
LIN, JT ;
LEE, CZ .
GASTROENTEROLOGY, 1985, 89 (02) :259-266
[38]   Early hepatocellular carcinoma as an entity with a high rate of surgical cure [J].
Takayama, T ;
Makuuchi, M ;
Hirohashi, S ;
Sakamoto, M ;
Yamamoto, J ;
Shimada, K ;
Kosuge, T ;
Okada, S ;
Takayasu, K ;
Yamasaki, S .
HEPATOLOGY, 1998, 28 (05) :1241-1246
[39]   Increase in primary liver cancer in the UK, 1979-94 [J].
TaylorRobinson, SD ;
Foster, GR ;
Arora, S ;
Hargreaves, S ;
Thomas, HC .
LANCET, 1997, 350 (9085) :1142-1143
[40]   RISK-FACTORS FOR HEPATOCELLULAR-CARCINOMA AMONG PATIENTS WITH CHRONIC LIVER-DISEASE [J].
TSUKUMA, H ;
HIYAMA, T ;
TANAKA, S ;
NAKAO, M ;
YABUUCHI, T ;
KITAMURA, T ;
NAKANISHI, K ;
FUJIMOTO, I ;
INOUE, A ;
YAMAZAKI, H ;
KAWASHIMA, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (25) :1797-1801